sIL2R level after CHOP-like regimen correlates with relapse-free survival in patients with PTCLs

Rika Sakai

Presentation information

Poster Session

Sun. Oct, 14

Poster Session 3-16 DLBCL: Prognostic factors

Sun. Oct 14, 2018 1:00 PM - 1:40 PM Poster2 (Osaka International Convention Center, 5F Main Foyer)

Chair: Hideki Tsujimura (Chiba Cancer Center)

[PS3-16-2] sIL2R level after CHOP-like regimen correlates with relapse-free survival in patients with PTCLs

Rika Sakai¹, Hirotaka Takasaki¹, Ayumi Numata¹, Megumi Koyama¹, Hideki Arakai¹, Kenji Motohashi¹, Takayuki Sakuma¹, Hideaki Nakajima² (1.Medical Oncol., Kanagawa Cancer Center, Yokohama, Japan, 2.Hematol. and Clinical Immunol, Yokohama City University School of Medicine)

Abstract password authentication.
Password is written on a program and abstract book.